Pharmacosmos A/S

🇩🇰Denmark

Country: 🇩🇰Denmark

Ownership: Subsidiary

Employees: -

Market Cap: -

Website: http://www.pharmacosmos.com

Clinical Trials

Iron Oligosaccharide in Inflammatory Bowel Disease Subjects With Iron Deficiency Anaemia

Phase 3

Completed

Conditions: Inflammatory Bowel Disease

Interventions: Drug: Iron Sulphate
Drug: Monofer

First Posted Date: 2009-11-20

Last Posted Date: 2012-11-27

Lead Sponsor: Pharmacosmos A/S

Target Recruit Count: 350

Registration Number: NCT01017614

Locations: 🇬🇧
Research Site, London, United Kingdom

A Study of Iron Oligosaccharide in CHF Patients

Phase 3

Completed

Conditions: Heart Failure, Congestive

Interventions: Drug: Iron oligosaccharide

First Posted Date: 2007-09-28

Last Posted Date: 2008-10-08

Lead Sponsor: Pharmacosmos A/S

Target Recruit Count: 20

Registration Number: NCT00537186

Locations: 🇩🇰
Roskilde University Hospital, Medicinsk afdeling, Roskilde, Denmark

A Study of Iron Oligosaccharide in Chronic Kidney Disease Patients

Phase 3

Completed

Conditions: Chronic Kidney Disease
Anemia, Iron-Deficiency

Interventions: Drug: Iron oligosaccharide

First Posted Date: 2007-09-28

Last Posted Date: 2008-10-08

Lead Sponsor: Pharmacosmos A/S

Target Recruit Count: 182

Registration Number: NCT00536666

Locations: 🇩🇰
Rigshospitalet, Nefrologisk afdeling P, Copenhagen, Denmark

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy